Call-to-Actions for 2022 were an integral part of the EEMEAI 2022 Kick-off. The Hemostasis team aimed to translate our Purpose Statement into CTAs by making a connection between why we do what we do as an organization and what we do in Hemostasis in EEMEAI.

In September, King Faisal Specialty Hospital and Research Center (the hospital) confirmed that all inhouse Thrombotic Thrombocytopenic Purpura (TTP) diagnosing and monitoring will be done with HemosIL AcuStar ADAMTS13 Activity assay in a 2-year deal, that includes a Bio-Flash analyzer for its autoimmunity laboratory.

One of the key aspects of clinical value selling is augmentation of ecosystem and market advocacy in the focus areas. Enablement and empowerment of the end user, in terms of clinical application of Werfen products and solutions, continues to drive clinical marketing strategy.

1st HemoHub installed in KSA

It is our pleasure to communicate that in July 2021 Abdullah Fouad Medical Systems, in collaboration with the EEMEAI team, successfully performed the first HemoHub installation in the Kingdom of Saudi Arabia.

WERFEN DOCS

Keeping our Partners fully updated on the latest news and product information from our Business Lines is one of the major goals we have at EEMEAI.

Therefore, with the support of Werfen IT dpt., we have developed a new and more innovative repository, that gathers all Service and Marketing documentation for Blood Gas, Clinical Chemistry, Hemostasis, PBM and WBH.

On May 26th and May 27th, we had the pleasure to spend several hours together each day sharing Hemostasis Diagnostics updates.

First ACL TOP LAS 750 installation in India

National Cancer Research Institute is located around 60 km away from Delhi in a town named Jhajjar.

This is a prestigious project of Union Government of India and is mainly aimed to optimize tertiary healthcare delivery care gap in Northern India.

IL ON DISPLAY AT ANNUAL ISTH CONGRESS

On July 7-9, the IL Hemostasis Diagnostics Management portfolio were on display at the Annual International Society on Thrombosis and Haemostasis (ISTH) Congress, held this year in Melbourne, Australia. 

Delivery of Results

In continuation with our "Connecting Value" meeting in April in Rome, we wanted to share amazing news regarding Hemostasis, Autoimmunity and Acute Care Diagnostics Lines and our collective ability as part of the EEMEAI world to continuously Deliver Results.  

A HemoCell Story… The Journey to Basel

Like every story, this HemoCell story has beginning a middle and an end. This story begins a long time ago when Universitätspital Basel was still an opportunity that was above the funnel.

Page 5 of 6

 

All rights reserved. © werfen.com

Get in touch

with the EEMEA team:

eemea@werfen.com

 

werfenplain

Issues

Go to top